Millipore evaluates strategic alternatives
Headquartered in Billerica, Millipore provides technologies, tools and services for the life science industry.
In a press release, Millipore "confirmed that its board of directors is evaluating strategic alternatives to enhance shareholder value, including by pursuing a process with potential bidders to explore a possible merger or sale of the company. The company has engaged Goldman Sachs as its financial advisor and Cravath, Swaine & Moore LLP as its legal advisor to assist the board in its evaluation."
Earlier this week, reports surfaced that Thermo Fisher Scientific, the laboratory science conglomerate based in Waltham, had made a $6 billion offer to buy Millipore. On Monday, spokeswomen for Thermo Fisher Scientific and Millipore separately declined to comment on the reports. (To read a Globe story about a possible deal, please click here.)
In its latest press release, Millipore said that it "has not set a definitive timetable for completion of its evaluation and there can be no assurances that the process will result in any transaction. The company does not intend to disclose developments regarding this process unless and until the board of directors has approved a specific transaction."